CXCR3-B Expression Correlates With Tumor Necrosis Extension in Renal Cell Carcinoma

Journal of Urology

Volumn 181, Issue 2, 2009, Pages 843-848

  Gacci, Mauro ^a   Serni, Sergio ^a   Lapini, Alberto ^a   Vittori, Gianni ^a   Alessandrini, Marco ^a   Nesi, Gabriella ^a   Palli, Domenico ^a   Carini, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

carcinoma; chemokines; CXCR3; kidney; necrosis; receptors; renal cell

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR NECROSIS; TUMOR VOLUME;

AGED; BIOPSY, NEEDLE; CARCINOMA, RENAL CELL; CHEMOKINE CXCL11; COHORT STUDIES; FEMALE; GENE EXPRESSION; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEPHRECTOMY; PROBABILITY; PROGNOSIS; RECEPTORS, CXCR3; RECEPTORS, CYTOKINE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TISSUE CULTURE TECHNIQUES; TUMOR MARKERS, BIOLOGICAL;

EID: 58149200895     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.10.063     Document Type: Article

References (20)

1. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121
2. Strier R.M., Polverini P.J., Kunkel S.L., Arenberg D.A., Burdick M.D., Kasper J., et al. The functional role of ERL motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270 (1995) 27348
3. Belperio J.A., Keane M.P., Arenberg D.A., Addison C.L., Ehlert J.E., Burdick M.D., et al. CXC chemokines in angiogenesis. J Leukoc Biol 68 (2000) 1
4. Romagnani P., Annunziato F., and Lasagni L. Cell cycle dependent expression of CXC chemokine receptor 3 by endothelial cell mediated angiostatic activity. J Clin Invest 107 (2001) 53
5. Lasagni L., Francalanci M., Annunziato F., Lazzeri E., Giannini S., Cosmi L., et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med 197 (2003) 1537
6. Lam J.S., Shvarts O., and Said J.W. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer 103 (2005) 2517
7. Mestas J., Burdick M.D., Reckamp K., Pantuck A., Figlin R.A., and Strieter R.M. The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol 175 (2005) 5351
8. Teichmann M., Meyer B., Beck A., and Niedobitek G. Expression of the interferon-inducible chemokine IP-10 (CXCL10), a chemokine with proposed anti-neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma. J Pathol 206 (2005) 68
9. Melillo R.M., Castellone M.D., Guarino V., De Falco V., Cirafici A.M., Salvatore G., et al. The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 115 (2005) 1068
10. Suyama T., Furuya M., Nishiyama M., Kasuya Y., Kimura S., Ichikawa T., et al. Up regulation of the interferon gamma-inducible chemokines IFN-inducible T cell alpha chemoattractant and monokine induced by IFN-gamma and their receptor CXC receptor 3 in human renal cell carcinoma. Cancer 103 (2005) 258
11. Kawada K., Sonoshita M., Sakashita H., Takabayashi A., Yamaoka Y., Manabe T., et al. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res 64 (2004) 4010
12. Goldberg-Bittman L., Neumark E., Sagi-Assif O., Azenshtein E., Meshel T., Witz I.P., et al. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines. Immunol Lett 92 (2004) 171
13. Datta D., Flaxenburg J.A., Laxmanan S., Geehan C., Grimm M., Waaga-Gasser A.M., et al. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer. Cancer Res 66 (2006) 9509
14. Klatte T., Seligson D., Loppert J., Riggs S., Zomorodian N., Kabbinavar F., et al. The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma. J Urol 179 (2008) 61
15. Sengupta S., Lohse C.M., Leibovich B.C., Frank I., Thompson R.H., Webster W.S., et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer 104 (2005) 511
16. Foria V., Surendra T., and Poller D.N. Prognostic relevance of extensive necrosis in renal cell carcinoma. J Clin Pathol 58 (2005) 39
17. Webster W.S., Lohse M.C., Thompson R.H., Dong H., Fridola X., Dicks D.L., et al. Mononuclear cell infiltration in clear cell renal cell carcinoma independently predicts patient survival. Cancer 107 (2006) 46
18. Pan J., Burdick M.D., Belperio J.A., Xue Y.Y., Gerard C., Sharma S., et al. CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis. J Immunol 176 (2006) 1456
19. Bukowsky R.M., Rayman P., Molto L., Tannenbaum C.S., Olencki T., Peereboom D., et al. Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma. Clin Cancer Res 5 (1999) 2780
20. Reckamp K.L., Figlin R.A., Moldawer N., Pantuck A.J., Belldegrun A.S., Burdick M.D., et al. Expression of CXCR3 on mononuclear cells and CXCR3 ligand in patients with metastatic renal cell carcinoma in response to systemic IL-2 therapy. J Immunother 30 (2007) 417